CBG: Emerging Cannabis Compound Shows Promise in Cancer and Pain Treatment
A new review highlights the therapeutic potential of cannabigerol (CBG), a lesser-known cannabinoid, in treating various conditions such as cancer, pain, and inflammatory disorders. The study, published in the journal Molecules, suggests CBG's unique molecular mechanisms and interactions with cannabinoid and other receptors could offer diverse therapeutic applications, including neuroprotection and antibacterial effects. While promising, further research, including human trials, is needed to fully understand CBG's potential and its synergy with other cannabinoids.
